FLT1 and prostate neoplasm: Finally, the prominent efficacy of the combined treatment comprising the use of docetaxel and 1,4-DMP is additionally confirmed by the decreased expression of VEGFR-1 (Fig. 2h), another prognostic marker that has been previously linked to enhanced metastatic potential of prostate tumors [44].